Saianand Commercial Limited is an India-based company. The Company is not engaged in any activity. It does not generate any revenue. The management is looking for an opportunity to make the Company operational.

Employees

Sector

Investment Holding Companies

More about the company

Quotes

Date	Price	Change	Volume
25/08/26	₹0.2000	-4.76%	1,661,047
24/08/26	₹0.2100	-4.55%	155,238
21/08/26	₹0.2200	0.00%	63,069
20/08/26	₹0.2200	+4.76%	161,628
19/08/26	₹0.2100	-4.55%	82,099

Delayed Quote Bombay S.E.

More quotes

Market Closed - Bombay S.E. 14:02:24 25/08/2026 +04			5-day change	1st Jan Change
0.2000 ^INR	-4.76%		-9.09%	-33.33%

08-06	Saianand Commercial Limited Reports Earnings Results for the First Quarter Ended June 30, 2026	CI
05-15	Saianand Commercial Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2026	CI

Market Cap	47.71M 500K 429K 402K 367K 693K 700K 4.74M 1.85M 24.07M 1.88M 1.84M 79.72M	P/E 2024	21.7x	P/E 2025	22.4x
Enterprise Value	73.38M 770K 660K 618K 565K 1.07M 1.08M 7.29M 2.84M 37.02M 2.89M 2.83M 123M	EV / Sales 2024	2,721,280x	EV / Sales 2025	4,249,293x
Free-Float	90.12%	Yield 2024 *	-	Yield 2025	-

08-06	Saianand Commercial Limited Reports Earnings Results for the First Quarter Ended June 30, 2026	CI
05-15	Saianand Commercial Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2026	CI
01-29	Saianand Commercial Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2025	CI
11-06	Saianand Commercial Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2025	CI
28/07/25	Saianand Commercial Limited Reports Earnings Results for the First Quarter Ended June 30, 2025	CI
21/05/25	Saianand Commercial Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2025	CI
31/01/25	Saianand Commercial Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2024	CI
28/01/25	Swagtam Trading & Services Limited announced that it expects to receive INR 61.904375 million in funding from Jalees Commercial Limited, Shree Ganesh Bio-Tech Limited, Amerise Biosciences Limited, Saianand Commercial Limited and other investors	CI
16/01/25	Saianand Commercial Limited Approves Resignation of Komal Chauhan as Independent Director	CI
12/11/24	Saianand Commercial Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2024	CI
10/09/24	Kunal H. Kothari, Prachi and Tejas K. Rathod completed the acquisition of 67.61% stake in Lucent Industries Limited from a group of shareholders.	CI
13/08/24	Saianand Commercial Limited Reports Earnings Results for the First Quarter Ended June 30, 2024	CI
30/05/24	Saianand Commercial Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2024	CI

1 day	-4.76%
1 week	-9.09%
Current month	-9.09%
1 month	-16.67%
3 months	-13.04%
6 months	-28.57%
Current year	-33.33%

Saianand Commercial Limited Stock

Stocks

SAICOM

INE092G01024

Investment Holding Companies

Valuation: Saianand Commercial Limited

Chart: Saianand Commercial Limited

Latest news : Saianand Commercial Limited

Quotes and Performance

Course Extremes

Managers and Directors: Saianand Commercial Limited

Shell Companies

Financials

Company Profile

Quotes

1 week	0.2	0.22
1 month	0.2	0.25
Current year	0.2	0.31
1 year	0.2	0.39
3 years	0.2	0.95
5 years	0.2	1.04
10 years	0.2	1.04

Manager	Title	Age	Since
Milanbhai Rameshbhai Khatri DFI	Director of Finance/CFO	43	26/12/2023
Bhagyashree Vinayak SEC	Corporate Secretary	-	30/05/2022

Director	Title	Age	Since
Gaurangkumar V. Vaishnav BRD	Director/Board Member	34	07/03/2019
Narendra Kumar Vaniya BRD	Director/Board Member	34	05/08/2022
Kajal Milan Khatri BRD	Director/Board Member	39	26/12/2023

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
SAIANAND COMMERCIAL LIMITED	-4.76%	-9.09%	-37.50%	-59.18%	498K
CHURCHILL CAPITAL CORP XI	+2.56%	-7.67%	-	-	785M
DRUGS MADE IN AMERICA ACQUISITION II CORP.	0.00%	+0.30%	-	-	647M
CENTIEL AG	+3.02%	-9.44%	+284.71%	-75.24%	607M
BAIN CAPITAL GSS INVESTMENT CORP.	-0.39%	+0.39%	-	-	603M
CHURCHILL CAPITAL CORP XII	+0.74%	+0.28%	-	-	597M
AMERICAN EXCEPTIONALISM ACQUISITION CORP. A	-0.52%	-0.35%	-	-	571M
CHURCHILL CAPITAL CORP XIII	+0.38%	+0.48%	-	-	508M
NEW AMERICA ACQUISITION I CORP.	-0.10%	-0.10%	-	-	506M
Average	+0.10%	-2.65%	+123.61%	-67.21%	535.96M
Weighted average by Cap.	+0.81%	-2.71%	+284.45%	-75.23%

	2024	2025
Net sales	54.23 0.57 0.49 0.46 0.42 0.79 0.8 5.39 2.1 27.36 2.14 2.09 90.61	24.75 0.26 0.22 0.21 0.19 0.36 0.36 2.46 0.96 12.49 0.97 0.95 41.36
Net income	7.59M 79.61K 68.22K 63.92K 58.39K 110K 111K 754K 294K 3.83M 299K 292K 12.68M	3.56M 37.31K 31.97K 29.96K 27.36K 51.64K 52.15K 353K 138K 1.79M 140K 137K 5.94M
Net Debt	-105K -1.1K -943.78 -884.33 -807.79 -1.52K -1.54K -10.43K -4.06K -52.98K -4.14K -4.05K -175K	25.67M 269K 231K 216K 197K 373K 376K 2.55M 993K 12.95M 1.01M 989K 42.88M